PNEUMOCOCCAL INFECTION
Clinical trials for PNEUMOCOCCAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine V116 shows promise for protecting High-Risk kids from pneumococcal disease
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called V116 in 882 children and teenagers (ages 2–17) who have a higher risk of getting pneumococcal disease due to conditions like diabetes, heart disease, or lung disease. The goal was to see if V116 is as good as or better than the current vacci…
Matched conditions: PNEUMOCOCCAL INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:40 UTC
-
New vaccine aims to shield High-Risk adults from pneumococcal disease
Prevention CompletedThis study tested a new pneumococcal vaccine (V116) in 518 adults aged 18-64 who are at higher risk for pneumococcal disease due to conditions like diabetes or chronic lung disease. The goal was to see if V116 is safe and triggers a strong immune response compared to existing vac…
Matched conditions: PNEUMOCOCCAL INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 11, 2026 20:41 UTC